Gene Therapy for Heart Failure: Back to the Bench-Reference-Cited by-同舟云学术

Gene Therapy for Heart Failure: Back to the Bench

Published:2015-10 Issue:10 Volume:23 Page:1551-1552
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Ylä-Herttuala Seppo

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference3 articles.

1. Celladon. Celladon reports negative results for CUPID2 trial of MYDICAR® in advanced heart failure Press release, 26 April 2015 http://ir.celladon.net/releasedetail.cfm?ReleaseID=908592

2. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure;Jessup;Circulation,2011

3. Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors;Gruchala;J Gene Med,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenging and target-based shifting strategies for heart failure treatment: An update from the last decades;Biochemical Pharmacology;2024-06

2. Advancements in gene therapy approaches for atrial fibrillation: Targeted delivery, mechanistic insights and future prospects;Current Problems in Cardiology;2024-04

3. Qifu Yixin Formula Improves Heart Failure by Enhancing β-Arrestin2 Mediated the SUMOylation of SERCA2a;Drug Design, Development and Therapy;2024-03

4. Cardiac-targeted rAAV5-S100A1 gene therapy protects against adverse remodeling and contractile dysfunction in post-ischemic hearts;2023-03-04

5. USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes;Circulation Research;2023-02-17